EditorialPublished 30 Sep 2024
Utilization of Biologics in Asthma and COPD
Department of Pulmonology, Kyoto University, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) significantly Open Access n a impact patient quality of life and healthcare systems worldwide. Traditional pharmacotherapy often falls short in managing severe cases, leading to the exploration of biologics as a novel treatment avenue. Biologics, targeting a r y R e i l t a t i o specific inflammatory pathways and immune responses, have emerged as effective therapies for patients with asthma and COPD. This article reviews the utilization of biologics in the management of asthma and COPD, discussing their mechanisms, clinical efficacy, safety profiles, and future directions in treatment strategies.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cardiac and Pulmonary Rehabilitation
- SubjectCardiology
- SubjectPulmonology & Respiratory
- SubjectPhysical Therapy & Rehabilitation
- BylineArticles whose byline prints “Dashiell Whitaker”